Undue : Actualité Undue en direct - P3 | Bourse Reflex
Accueil > Tags > Undue

  • Toutes les actualités en rapport avec « Undue »

31/03 16:45 Undue - Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

24/03 15:55 Undue - Apricus Biosciences Adopts Shareholder Rights Plan

22/03 14:55 Undue - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

15/03 15:30 Undue - Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)

10/03 16:00 Undue - Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

08/03 16:00 Undue - Apricus Biosciences Announces Removal of Auditor's "Going Concern" Opinion From Its 2010 Form 10-K and Increased Cash Reserves

08/03 14:00 Undue - Brightpoint Announces Successful Go-Live of Center of Excellence in Boras, Sweden

01/03 15:15 Undue - Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

01/03 12:30 Undue - RR Donnelley and KBA Announce Agreement to Develop and Deliver Next Generation Digital Print Platforms

17/02 15:15 Undue - Apricus Biosciences and FDA Initiate PrevOnco(TM) SPA Phase III Clinical Protocol Discussion

16/02 08:50 Undue - "Play" With Rihanna

14/02 16:15 Undue - Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to USD 4.35 Million, Plus Royalties

10/02 16:15 Undue - Apricus Biosciences to Present Review of Commercialization Plans for Vitaros(R) and Development of Product Pipeline at BioPartnering North America Conference(TM)

25/01 12:30 Undue - RR Donnelley Secures Multi-Million Dollar, Multi-Year Customer Communications Management Contract

24/01 12:30 Undue - Raptor Pharmaceutical Completes Enrollment in Pivotal Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

19/01 17:45 Undue - Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Therapy, Loceryl(R)

19/01 14:00 Undue - Brightpoint Announces Re-Entry Into Poland

23/12 09:00 Undue - Apricus Biosciences and Bracco Sign Licensing Agreement for Vitaros(R) in Italy

15/12 12:45 Undue - American Airlines Expands Long-Time Descartes Relationship to Include EU Regulatory Compliance

07/12 18:00 Undue - Black Dragon Discusses Company Objectives